Showing results (1611-1620 of 1,820) with videos related to
Sort By:
Pageof 182
Pulmonary Circulation|May 11, 2013
Advancing clinical trial design in pulmonary hypertensionAndy P Grieve, Shien-Chung Chow, John Curram, et al.Pulmonary Circulation|May 11, 2013
Clinical trials in pulmonary hypertension: Time for a consortiumJohn H Newman, Gregory C Elliott, Glennis S Haworth, et al.Pulmonary Circulation|May 11, 2013
Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committeeIan Adatia, Sheila G Haworth, Max Wegner, et al.Pulmonary Circulation|July 10, 2014
Bone marrow-derived vascular modulatory cells in pulmonary arterial hypertensionEmily Lanzola, Samar Farha, Serpil C Erzurum, et al.Pulmonary Circulation|July 10, 2014
Safety of cardiac catheterization at a center specializing in the care of patients with pulmonary arterial hypertensionWarren A Zuckerman, Mariel E Turner, Jason Kerstein, et al.Pulmonary Circulation|July 10, 2014
Transition from prostacyclin analogue infusion to oral therapy in patients with pulmonary arterial hypertension: a 5-year follow-upEsteban Escolar, Andrés M Pineda, Barbara Correal, et al.Pulmonary Circulation|July 10, 2014
Study design and rationale for investigating phosphodiesterase type 5 inhibition for the treatment of pulmonary hypertension due to chronic obstructive lung disease: the TADA-PHiLD (TADAlafil for Pulmonary Hypertension associated with chronic obstructive Lung Disease) trialBradley A Maron, Ronald H Goldstein, Sharon I Rounds, et al.Pulmonary Circulation|July 10, 2014
The peroxisome proliferator-activated receptor β/δ agonist GW0742 has direct protective effects on right heart hypertrophyBaktybek Kojonazarov, Himal Luitel, Akylbek Sydykov, et al.Pulmonary Circulation|July 10, 2014
Right heart failure: toward a common languageMandeep R Mehra, Myung H Park, Michael J Landzberg, et al.Pulmonary Circulation|July 10, 2014
Effects of dose and age on adverse events associated with tadalafil in the treatment of pulmonary arterial hypertensionErika Berman-Rosenzweig, Carl Arneson, James R KlingerPageof 182